BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22725674)

  • 1. Male-to-female gender ratio in fetuses with increased nuchal translucency.
    Daouk ME; Brustman L; Langer O; Lysikiewicz A
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2613-5. PubMed ID: 22725674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency.
    Timmerman E; Pajkrt E; Bilardo CM
    Ultrasound Obstet Gynecol; 2009 Oct; 34(4):373-8. PubMed ID: 19618399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
    Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age.
    Mula R; Goncé A; Bennásar M; Arigita M; Meler E; Nadal A; Sánchez A; Botet F; Borrell A
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):34-41. PubMed ID: 21837766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuchal translucency thickness in euploid fetuses: is two millimeters too risky?
    Fink M; Sheiner E; Sheizaf B; Hershkovitz R; Bashiri A; Mazor M; Wiznitzer A
    Am J Perinatol; 2009 Apr; 26(4):303-7. PubMed ID: 19031359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac.
    Bekker MN; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM
    Obstet Gynecol; 2006 Oct; 108(4):846-53. PubMed ID: 17012445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
    Bronshtein M; Zimmer EZ; Blazer S
    Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population.
    Westin M; Saltvedt S; Almström H; Grunewald C; Valentin L
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):150-8. PubMed ID: 17211897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
    Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of a detailed first trimester anomaly scan in fetuses with increased nuchal translucency thickness.
    Tekesin I
    J Perinat Med; 2019 Feb; 47(2):241-246. PubMed ID: 30218607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.
    Spencer K; Cowans NJ; Avgidou K; Molina F; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):15-9. PubMed ID: 17999381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the contents of exomphalos and nuchal translucency at 11-14 weeks on the likelihood of associated chromosomal abnormality.
    Iacovella C; Contro E; Ghi T; Pilu G; Papageorghiou A; Thilaganathan B; Bhide A
    Prenat Diagn; 2012 Nov; 32(11):1066-70. PubMed ID: 22961234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The added value of detailed early anomaly scan in fetuses with increased nuchal translucency.
    Zalel Y; Zemet R; Kivilevitch Z
    Prenat Diagn; 2017 Mar; 37(3):235-243. PubMed ID: 28010037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Karyotype and outcome of fetuses diagnosed with cystic hygroma in the first trimester in relation to nuchal translucency thickness.
    Kharrat R; Yamamoto M; Roume J; Couderc S; Vialard F; Hillion Y; Ville Y
    Prenat Diagn; 2006 Apr; 26(4):369-72. PubMed ID: 16566042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there any relationship between adverse pregnancy outcome and first trimester nuchal translucency measurements in normal karyotype fetuses?
    Uysal F; Coşar E; Yücesoy K; Gencer M; Cevizci S; Güngör A; Hacıvelioğlu S; Uysal A
    J Matern Fetal Neonatal Med; 2015 Mar; 28(5):531-4. PubMed ID: 24824104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome of euploid fetuses with increased nuchal translucency: how bad is the news?
    Maymon R; Weinraub Z; Herman A
    J Perinat Med; 2005; 33(3):191-8. PubMed ID: 15914340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
    Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z
    Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.